Biotech Stocks Featured Penny Stock News Penny Stocks Watch List

5 Penny Stocks To Watch If You’re Concerned About Coronavirus

Sign up for our FREE Newsletter and get:

  • The Beginner’s Handbook For Trading Penny Stocks
  • Penny Stock Alerts And Ideas
  • Learn To Trade Penny Stocks
  • Free Access to The Fastest Growing Highest Rated Trading Chatroom

Coronavirus Penny Stocks #4: Oncolytics Biotech (ONCY)

Next, Oncolytics Biotech (ONCY – Free Report) is a company known for developing treatments for deadly viruses as well as cancers. However, it should be mentioned that ONCY may be a bit far off the path of a company working to find a vaccine for coronavirus. The main focus of the company is on cancer. But in your search to find coronavirus stocks, you may come across Oncolytics.

Regardless of its progress in that light, the company does have an active pipeline developing different cancer therapies. Furthermore, Oncolytics has a laundry list of partnerships with larger biotech firms. These include Roche, Pfizer, Merck, and Bristol-Myers Squibb. It’s pipeline includes treatments in numerous clinical phases and in combination with proven drugs. Keytruda, Tecentriq, Opdivo, and Bavencio are all being combined with Oncolytics lead therapy, pelareorep.

So if coronavirus stocks are your focus, Oncolytics may not be “the one.” However, from a cancer stock angle, it may be worth understanding a bit more on its treatment pipeline. Pelareorep has applications for breast cancer treatments, GI cancer treatments, and multiple myeloma treatments right now.

By J. Samuel

As a trader and expert finance writer, I enjoy finding new and emerging trends that may have been overlooked by the average masses. If there's one thing that a trader or investor wants to know, it's how to use valuable data to their advantage. My expertise is in uncovering this data and compiling it into actionable information. As a professional finance writer, I've contributed to many of the top finance platforms and pride myself on researching factual, publicly available information and using that in all of my articles.

Leave a Reply

Your email address will not be published. Required fields are marked *